Mylan is Endo's top competitor. Mylan was founded in 1961 in Canonsburg, Pennsylvania. Mylan competes in the Pharmaceuticals field. Mylan generates $8.5B more revenue than Endo.
Allergan is perceived as one of Endo's biggest rivals. Allergan's headquarters is in Coolock, County Dublin, and was founded in 1948. Allergan is in the Health Care Supplies industry. Allergan generates 533% of Endo's revenue.
August 7, 2020
August 8, 2020
August 7, 2020
Endo's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 10.1B. Over the last four quarters, Endo's revenue has decreased by 5.7%. Specifically, in Q2 2020's revenue was $687.6M; in Q1 2020, it was $820.4M; in Q4 2019, it was $764.8M; in Q3 2019, Endo's revenue was $729.4M.
These are all the companies that Endo has acquired. Endo has acquired 8 companies and its latest acquisition was Somerset Therapeutics, LLC in Apr 2018. Somerset is a sterile pharmaceutical company that manufactures and markets injectable and ophthalmic drugs for the US marketplace.
Since Endo was founded in 1997, it has participated in 2 rounds of funding. In total Endo has raised $2.8B. Endo's last funding round was on Feb 2019 for a total of $5.7M
No recent investments found related to Endo
Endo currently has 429 fans on Facebook. As of July 2013 Endo had 399 fans. That's a 7 percent increase in 1year
Endo currently has 946 followers on Twitter. As of July 2013 Endo had 510 followers. That's a 85 percent increase in 4 years
Simmonscourt Road First Floor, Minerva House
Ballsbridge, County Dublin
353-1-268-2000Driving Directions »